Trials / Completed
CompletedNCT04970199
Cardiovascular Protective Role of Laser Acupuncture in Systemic Lupus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 47 Years
- Healthy volunteers
- Not accepted
Summary
Systemic lupus erythematosus is a chronic and multisystemic autoimmune disorder which predominantly affecting women. The most common cause of death in lupus patients affected by disease for more than 5 years is cardiovascular disease due to presence of some factors as oxidative stress, pro-inflammatory cytokines , dyslipidemia, diabetes, and hypertension.
Detailed description
laser acupuncture (active or sham) for one month (3 days/week ) on acupoint number 14 of GV meridian, acupoint number 4 and 11 of large intestine, acupoint number 34 of gall bladder meridian, acupoint number 3 of liver meridian, acupoint number 4, 12, and 9 of conception vessel meridian, acupoint number 40, 36, and 25 of stomach meridian, acupoint number 6 of spleen meridian, and acupoint number 5 of triple energizer meridian (laser will be applied for 1 min on every acupiont) in lupus females
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | laser application on acupoints | laser acupuncture |
Timeline
- Start date
- 2021-07-12
- Primary completion
- 2021-11-10
- Completion
- 2021-11-30
- First posted
- 2021-07-21
- Last updated
- 2022-01-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04970199. Inclusion in this directory is not an endorsement.